Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Smith & Nephew buys Healthpoint Biotherapeutics for $782 mln  Join our daily free Newsletter

MENAFN - ProactiveInvestors - Australia - 29/11/2012

No. of Ratings : 0
Add to Mixx!


 


Medical tech company Smith & Nephew has agreed to buy Healthpoint Biotherapeutics for $782 million in cash in a bid to expand its wound management division.
(MENAFN - ProactiveInvestors - Australia) Medical tech company Smith & Nephew (LON:SN) (NYSE:SNN) has agreed to buy Healthpoint Biotherapeutics for 782 million in cash in a bid to expand its wound management division.

The deal, which still needs regulatory approval, is expected to close in December.

Healthpoint Biotherapeutics is focused on acute, chronic, and burn-related wound care, led by sales of Collagenase Santyl ointment. It has also developed a new cell therapy, HP802-247, which completed a successful phase 2b study in 2011 and for which a North American phase 3 trial was initiated this past September.

The therapy consists of two components that are sprayed sequentially on the wound bed at the time of treatment: a fibrinogen solution and a cell preparation containing a mixture of growth arrested, living, allogeneic epidermal keratinocytes and dermal fibroblasts.

These living cells are expected to interact with the patient's own cells to stimulate wound healing. The double-blind phase 2b study involved 228 subjects enrolled across 35 centers in the US. Overall, the company said HP802-247 achieved "statistical significance", as compared with control plus standard care, in both the primary and secondary endpoints.

"The acquisition of Healthpoint is an important step for Smith & Nephew, and for our Advanced Wound Management division," said CEO Olivier Bohuon.

"Strategically, it gives us a strong position in the fastest growing area of advanced wound management " bioactives. And it does this bringing material revenues from a fast growing product range, an attractive pipeline, and the commercial and R&D capabilities upon which we can build.

"The combination creates a truly unique wound care business " having leadership positions across exudate and infection management, negative pressure and bioactives to offer to our customers."

 






  MENA News Headlines


 
Click to Apply






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help